These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6998041)

  • 1. Plasma urokinase levels measured by chromogenic assay after infusions of tissue culture or urinary source material.
    Barlow GH; Marder VJ
    Thromb Res; 1980 May 1-15; 18(3-4):431-7. PubMed ID: 6998041
    [No Abstract]   [Full Text] [Related]  

  • 2. Assay of urokinase activity in plasma with a chromogenic substrate.
    Hayashi S; Yamada K
    Thromb Res; 1981 Jun 1-25; 22(5-6):573-8. PubMed ID: 6171046
    [No Abstract]   [Full Text] [Related]  

  • 3. Demonstration of urokinase-related fibrinolytic activity in human plasma.
    Wijngaards G; Kluft C; Groeneveld E
    Br J Haematol; 1982 May; 51(1):165-9. PubMed ID: 7041952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation from human plasma of a plasminogen activator identical to urinary high molecular weight urokinase.
    Tissot JD; Schneider P; Hauert J; Ruegg M; Kruithof EK; Bachmann F
    J Clin Invest; 1982 Dec; 70(6):1320-3. PubMed ID: 6757269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the plasma fibrinolytic system during urokinase therapy: comparison of tissue culture urokinase with urinary source urokinase in patients with pulmonary embolism.
    Marder VJ; Donahoe JF; Bell WR; Cranley JJ; Kwaan HC; Sashara AA; Barlow GH
    J Lab Clin Med; 1978 Nov; 92(5):721-9. PubMed ID: 712206
    [No Abstract]   [Full Text] [Related]  

  • 6. Some notes on the question of the hypotensive activity of urokinase.
    Caprino L; Borrelli F; Bergesi G; Marchetti E
    Thromb Haemost; 1979 Aug; 42(2):820-1. PubMed ID: 505389
    [No Abstract]   [Full Text] [Related]  

  • 7. [The changes of alpha 2-plasmin inhibitor, and notably urokinase activities in blood measured by synthetic chromogenic substrates S-2444 after urokinase administration].
    Itoh Y; Tsuji K; Tanaka N; Yamada M; Nakanishi M; Ishihara M; Kobayashi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jan; 35(1):68-76. PubMed ID: 6338134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibition of high and low molecular weight urokinase in plasma.
    Murano G; Aronson D; Williams L; Brown L
    Blood; 1980 Mar; 55(3):430-6. PubMed ID: 6444529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromogenic assay for equine plasminogen.
    Welles EG; Prasse KW; Duncan A
    Am J Vet Res; 1990 Jul; 51(7):1080-5. PubMed ID: 1697146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of furosemide on plasma fibrinolytic activity and urokinase excretion.
    Chohan IS; Singh I; Vermylen J; Verstraete M
    Exp Hematol; 1977 Mar; 5(2):153-7. PubMed ID: 844519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chromogenic enzymatic assay capable of detecting prourokinase-like material in plasma.
    Kebabian PR; Henkin J
    Thromb Res; 1992 Feb; 65(3):401-7. PubMed ID: 1631804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic studies of urokinase metabolism.
    Matsuo O; Mihara H
    Thromb Res; 1977 Oct; 11(4):531-41. PubMed ID: 918910
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation and characterization of urokinase from human plasma.
    Wun TC; Schleuning WD; Reich E
    J Biol Chem; 1982 Mar; 257(6):3276-83. PubMed ID: 7037781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Threshold phenomena in blood fibrinolysis.
    Matsuo O; Mihara H
    Thromb Res; 1977 May; 10(5):753-8. PubMed ID: 882961
    [No Abstract]   [Full Text] [Related]  

  • 15. Excessive fibrinolysis in amyloidosis associated with elevated plasma single-chain urokinase.
    Liebman HA; Carfagno MK; Weitz IC; Berard P; Diiorio JM; Vosburgh E; Simms RW
    Am J Clin Pathol; 1992 Nov; 98(5):534-41. PubMed ID: 1485607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical properties of highly purified kidney cultured plasminogen activator (single chain urokinase).
    Sumi H; Kosugi T; Matsuo O; Mihara H
    Nihon Ketsueki Gakkai Zasshi; 1982 Feb; 45(1):119-28. PubMed ID: 7051725
    [No Abstract]   [Full Text] [Related]  

  • 17. Spectrometric determination of urokinase in urine after gel filtration, using the chromogenic substrate S-2444.
    Paar D; Maruhn D
    J Clin Chem Clin Biochem; 1980 Sep; 18(9):557-62. PubMed ID: 7003055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urinary urokinase and blood fibrinolytic activity in patients with diabetes mellitus].
    Kaniak J; Kotschy M; Janukowicz-Lorenz H; Plamieniak L
    Pol Tyg Lek; 1975 Dec; 30(48):1889-91. PubMed ID: 1197079
    [No Abstract]   [Full Text] [Related]  

  • 19. The comparison of solid phase and fibrin plate methods for the measurement of plasminogen activators.
    Millar WT; Smith JF
    Thromb Res; 1983 Jun; 30(5):431-9. PubMed ID: 6351344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on activator formation in human plasma with streptokinase. III. Investigation of activator kinetics in undiluted plasma in terms of urokinase equivalents.
    Martin M
    Thromb Haemost; 1976 Dec; 36(3):566-81. PubMed ID: 138962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.